$16.44+0.03 (+0.18%)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.
Select Medical Holdings Corporation in the Healthcare sector is trading at $16.44. The stock is currently near its 52-week high of $16.99, remaining 13.6% above its 200-day moving average. Technical signals show neutral RSI of 61 and bearish MACD signal, explaining why SEM maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists...
Thomas Mullen: Thank you, operator, and good morning, everyone. Welcome to Select Medical Holdings Corporation's earnings call for 2026. On March 2, 2026, we announced that Select Medical Holdings Corporation entered into an agreement to be acquired by a consortium led by our Executive Chairman, Robert Ortenzio, together with Martin Jackson and Welsh, Carson, Anderson & Stowe.
Moby summary of Select Medical Holdings Corporation's Q1 2026 earnings call
Shareholders appeared unconcerned with 7-Eleven Malaysia Holdings Berhad's ( KLSE:SEM ) lackluster earnings report last...
Select Medical (SEM) delivered earnings and revenue surprises of -15.91% and +1.54%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Healthcare services company Select Medical (NYSE:SEM) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 5% year on year to $1.42 billion. The company expects the full year’s revenue to be around $5.7 billion, close to analysts’ estimates. Its GAAP profit of $0.35 per share was 23.8% below analysts’ consensus estimates.